Literature DB >> 31260000

Evaluating Open Payments.

Genevieve P Kanter1,2, George Loewenstein3.   

Abstract

Year:  2019        PMID： 31260000     DOI： 10.1001/jama.2019.8171

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Lessons from Corporate Influence in the Opioid Epidemic: Toward a Norm of Separation.

Authors:  Jonathan H Marks
Journal:  J Bioeth Inq       Date:  2020-07-13       Impact factor: 1.352

2.  The Sun Is Still Shining: Nature of Industry Payments to Transplant Surgeons From 2014 to 2019.

Authors:  Conner V Lombardi; Jacob J Lang; Deklin Clayton; Puneet Sindhwani; Michael Rees; Obi Ekwenna
Journal:  Transplant Direct       Date:  2022-04-21

3.  Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.

Authors:  Kosuke Inoue; Yusuke Tsugawa; Carol M Mangione; O Kenrik Duru
Journal:  PLoS Med       Date:  2021-06-01       Impact factor: 11.069

4.  Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016.

Authors:  Marlene Stoll; Lara Hubenschmid; Cora Koch; Klaus Lieb
Journal:  BMJ Open       Date:  2020-09-17       Impact factor: 2.692

5.  Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians.

Authors:  Anju Murayama; Yuki Senoo; Kayo Harada; Yasuhiro Kotera; Hiroaki Saito; Toyoaki Sawano; Yosuke Suzuki; Tetsuya Tanimoto; Akihiko Ozaki
Journal:  Int J Environ Res Public Health       Date:  2022-03-15       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.